Skip to main navigation Skip to search Skip to main content
Nikolaos Robakis

View Scopus Profile

Nikolaos Robakis

PhD

1981 …2026

Research activity per year

Personal profile

Headline

PROFESSOR | Psychiatry PROFESSOR | Neuroscience

Biography

Dr. Robakis is A.P. Slaner Professor for Alzheimer's Disease Research and is Director of the http://www.mssm.edu/research/labs/robakis-laboratory Robakis Laboratory. Training Areas: Neurobiology, Molecular Biology, Molecular Basis of Disease. Multi-Disciplinary Training Areas Genetics and Genomic Sciences [GGS], Neuroscience [NEU] Education PhD, New York University

Fingerprint

Dive into the research topics where Nikolaos Robakis is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles
View full fingerprint

Collaborations and top research areas from the last five years

Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Explore network further

  • Serious side effects of Alzheimer’s immunotherapy demand scrutiny

    Høilund-Carlsen, P. F., Alavi, A., Andalib, S., Castellani, R. J., Costa, T., de Girolamo, G., Espay, A. J., Neve, R. L., Perry, G., Revheim, M. E., Robakis, N. K., Sensi, S. L., Vissel, B. & Barrio, J. R., Jul 2026, In: Ageing Research Reviews. 119, 103151.

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • Restoring amyloid-β42 and γ-secretase function in Alzheimer's disease

    Espay, A. J., Ezzat, K., Kepp, K. P., Daly, T., Robakis, N. K., Meijer, L. & Imbimbo, B. P., 1 Nov 2025, In: Brain. 148, 11, p. 3856-3864 9 p.

    Research output: Contribution to journal › Review article › peer-review

    4 Scopus citations

  • Basic Science and Pathogenesis

    Dey, P., Pandey, R., Zarrouk, A., Tzikas, G., Georgakopoulos, A. & Robakis, N. K. R. K., 1 Dec 2024, In: Alzheimer's and Dementia. 20, p. e092786

    Research output: Contribution to journal › Article › peer-review

    Open Access

  • Donanemab, another anti-Alzheimer's drug with risk and uncertain benefit

    Høilund-Carlsen, P. F., Alavi, A., Barrio, J. R., Castellani, R. J., Costa, T., Herrup, K., Kepp, K. P., Neve, R. L., Perry, G., Revheim, M. E., Robakis, N. K., Sensi, S. L. & Vissel, B., Aug 2024, In: Ageing Research Reviews. 99, 102348.

    Research output: Contribution to journal › Review article › peer-review

    Open Access
    29 Scopus citations

  • Revision of Alzheimer's diagnostic criteria or relocation of the Potemkin village

    Høilund-Carlsen, P. F., Alavi, A., Barrio, J. R., Castellani, R. J., Costa, T., Herrup, K., Kepp, K. P., Neve, R. L., Perry, G., Revheim, M. E., Robakis, N. K., Sensi, S. L. & Vissel, B., Jan 2024, In: Ageing Research Reviews. 93, 102173.

    Research output: Contribution to journal › Review article › peer-review

    Open Access
    7 Scopus citations
View all 160 Research outputs